Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11130
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSeeman, Egoen
dc.date.accessioned2015-05-16T00:43:03Z
dc.date.available2015-05-16T00:43:03Z
dc.date.issued2010-12-01en
dc.identifier.citationJournal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research; 25(12): 2553-7en
dc.identifier.govdoc20928873en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11130en
dc.language.isoenen
dc.subject.otherAlendronate.pharmacology.therapeutic useen
dc.subject.otherBone Density.drug effectsen
dc.subject.otherBone Density Conservation Agents.pharmacology.therapeutic useen
dc.subject.otherBone Resorption.drug therapy.physiopathologyen
dc.subject.otherBone and Bones.drug effects.pathology.physiopathology.radiographyen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherTomography, X-Ray Computeden
dc.titleBone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Bone and Mineral Researchen
dc.identifier.affiliationDepartment of Endocrinology and Medicine, Austin Health, University of Melbourne, Melbourne, Australiaen
dc.identifier.doi10.1002/jbmr.261en
dc.description.pages2553-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/20928873en
dc.type.austinJournal Articleen
local.name.researcherSeeman, Ego
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.